Total Payments
$1,160
2024 Payments
$138.96
Companies
9
Transactions
25
Medicare Patients
6,122
Medicare Billing
$3.3M
Payment Breakdown by Category
Food & Beverage$1,113 (96.0%)
Education$46.25 (4.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,113 | 23 | 96.0% |
| Education | $46.25 | 2 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $485.46 | 7 | $0 (2024) |
| AbbVie, Inc. | $186.04 | 3 | $0 (2017) |
| Genentech USA, Inc. | $171.82 | 8 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $121.83 | 1 | $0 (2019) |
| Allergan Inc. | $92.95 | 1 | $0 (2017) |
| Apellis Pharmaceuticals, Inc. | $44.04 | 2 | $0 (2024) |
| Coherus Biosciences Inc. | $24.75 | 1 | $0 (2023) |
| Astellas Pharma US Inc | $19.05 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $13.57 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $138.96 | 6 | Regeneron Healthcare Solutions, Inc. ($47.33) |
| 2023 | $122.14 | 6 | Genentech USA, Inc. ($79.58) |
| 2022 | $45.89 | 2 | Genentech USA, Inc. ($45.89) |
| 2021 | $121.86 | 1 | Regeneron Healthcare Solutions, Inc. ($121.86) |
| 2019 | $284.40 | 4 | Regeneron Healthcare Solutions, Inc. ($149.00) |
| 2017 | $446.26 | 6 | AbbVie, Inc. ($186.04) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Ophthalmology | ||||||
| 11/11/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/19/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/29/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/29/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Education | In-kind items and services | $19.83 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/05/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Ophthalmology | ||||||
| 08/15/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $17.81 | General |
| Category: Ophthalmology | ||||||
| 07/17/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/01/2023 | Coherus Biosciences Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Ophthalmology | ||||||
| 02/20/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Immunology and Ophthalmology | ||||||
| 01/23/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Immunology and Ophthalmology | ||||||
| 01/23/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/21/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/03/2022 | Genentech USA, Inc. | Lucentis (Biological), VABYSMO | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Ophthalmology | ||||||
| 09/24/2021 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $121.86 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/26/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $122.58 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/28/2019 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/21/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Education | In-kind items and services | $26.42 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/12/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 11/11/2017 | Regeneron Healthcare Solutions, Inc. | EYLEA AFLIBERCEPT INJECTION (Biological) | Food and Beverage | In-kind items and services | $78.12 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/27/2017 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $92.95 | General |
| Category: RETINA | ||||||
| 07/20/2017 | Regeneron Healthcare Solutions, Inc. | EYLEA AFLIBERCEPT INJECTION (Biological) | Food and Beverage | In-kind items and services | $89.15 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/12/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Immunology | ||||||
| 06/07/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $83.88 | General |
| Category: Immunology | ||||||
| 03/16/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $89.02 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,414 | 5,440 | $4.7M | $725,518 |
| 2022 | 12 | 1,475 | 5,607 | $4.8M | $791,820 |
| 2021 | 13 | 1,718 | 5,990 | $5.0M | $890,784 |
| 2020 | 11 | 1,515 | 5,651 | $4.8M | $848,968 |
Total Patients
6,122
Total Services
22,688
Medicare Billing
$3.3M
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 39 | 545 | $1.4M | $347,310 | 25.6% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 28 | 880 | $1.3M | $158,780 | 12.0% |
| 67028 | Injection of drug into eye | Office | 2023 | 195 | 1,144 | $1.4M | $95,513 | 6.8% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 134 | 759 | $94,875 | $40,738 | 42.9% |
| 92134 | Imaging of retina | Office | 2023 | 468 | 1,466 | $363,568 | $39,680 | 10.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 240 | 293 | $87,900 | $23,001 | 26.2% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 96 | 96 | $33,600 | $9,622 | 28.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 53 | 80 | $16,000 | $4,662 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 45 | $7,875 | $2,858 | 36.3% |
| 92250 | Photography of the retina | Office | 2023 | 94 | 105 | $19,425 | $2,441 | 12.6% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 24 | 27 | $12,015 | $912.49 | 7.6% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 46 | 649 | $1.5M | $395,502 | 26.6% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 32 | 885 | $1.2M | $174,244 | 14.6% |
| 67028 | Injection of drug into eye | Office | 2022 | 216 | 1,136 | $1.5M | $95,764 | 6.6% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 146 | 795 | $99,500 | $40,374 | 40.6% |
| 92134 | Imaging of retina | Office | 2022 | 468 | 1,480 | $367,040 | $40,088 | 10.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 250 | 300 | $90,000 | $23,629 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 75 | 75 | $30,000 | $8,383 | 27.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 76 | 105 | $21,000 | $6,065 | 28.9% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 31 | 31 | $10,850 | $3,353 | 30.9% |
| 92250 | Photography of the retina | Office | 2022 | 105 | 116 | $21,460 | $2,802 | 13.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $3,060 | $844.91 | 27.6% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 18 | 23 | $10,235 | $769.46 | 7.5% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 46 | 625 | $1.6M | $428,469 | 27.3% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2021 | 31 | 925 | $1.2M | $207,116 | 16.7% |
About Dr. Brett Gerwin, M.D
Dr. Brett Gerwin, M.D is a Retina Specialist healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1306992003.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brett Gerwin, M.D has received a total of $1,160 in payments from pharmaceutical and medical device companies, with $138.96 received in 2024. These payments were reported across 25 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,113).
As a Medicare-enrolled provider, Gerwin has provided services to 6,122 Medicare beneficiaries, totaling 22,688 services with total Medicare billing of $3.3M. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology, Ophthalmology
- Location Chattanooga, TN
- Active Since 01/26/2007
- Last Updated 11/11/2021
- Taxonomy Code 207WX0107X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306992003
Products in Payments
- EYLEA (Biological) $270.86
- Humira (Biological) $186.04
- EYLEA AFLIBERCEPT INJECTION (Biological) $167.27
- Vabysmo (Drug) $125.93
- ACTHAR (Biological) $121.83
- OZURDEX (Drug) $92.95
- EYLEA HD (Biological) $47.33
- Syfovre (Drug) $44.04
- Cimerli (Biological) $24.75
- Lucentis (Biological) $24.17
- VABYSMO (Drug) $21.72
- Izervay (Drug) $19.05
- BEOVU (Drug) $13.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.